- Home
- ORIC vs CAPL Comparison
ORIC vs CAPL Comparison
Compare ORIC & CAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- CAPL
- Stock Information
- Founded
- ORIC 2014
- CAPL 1992
- Country
- ORIC United States
- CAPL United States
- Employees
- ORIC N/A
- CAPL N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- CAPL Oil Refining/Marketing
- Sector
- ORIC Health Care
- CAPL Energy
- Exchange
- ORIC Nasdaq
- CAPL Nasdaq
- Market Cap
- ORIC 974.1M
- CAPL 793.6M
- IPO Year
- ORIC 2020
- CAPL 2012
- Fundamental
- Price
- ORIC $10.88
- CAPL $20.53
- Analyst Decision
- ORIC Strong Buy
- CAPL
- Analyst Count
- ORIC 10
- CAPL 0
- Target Price
- ORIC $17.33
- CAPL N/A
- AVG Volume (30 Days)
- ORIC 782.2K
- CAPL 30.3K
- Earning Date
- ORIC 08-12-2025
- CAPL 11-05-2025
- Dividend Yield
- ORIC N/A
- CAPL 10.23%
- EPS Growth
- ORIC N/A
- CAPL 100.77
- EPS
- ORIC N/A
- CAPL 1.13
- Revenue
- ORIC N/A
- CAPL $3,522,840,000.00
- Revenue This Year
- ORIC N/A
- CAPL N/A
- Revenue Next Year
- ORIC N/A
- CAPL N/A
- P/E Ratio
- ORIC N/A
- CAPL $18.22
- Revenue Growth
- ORIC N/A
- CAPL N/A
- 52 Week Low
- ORIC $3.90
- CAPL $19.42
- 52 Week High
- ORIC $14.67
- CAPL $25.73
- Technical
- Relative Strength Index (RSI)
- ORIC 63.04
- CAPL 44.83
- Support Level
- ORIC $9.87
- CAPL $20.35
- Resistance Level
- ORIC $10.35
- CAPL $21.17
- Average True Range (ATR)
- ORIC 0.44
- CAPL 0.49
- MACD
- ORIC 0.14
- CAPL 0.02
- Stochastic Oscillator
- ORIC 79.99
- CAPL 28.33
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About CAPL CrossAmerica Partners LP Common Units representing limited partner interests
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.